Delivery Order SPE2DB22D3501-SPE2DB26FTE80
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Prolia 60 mg/ml syringes. This competitive, firm fixed-price delivery order has a ceiling value of $10,714.50 and an ultimate completion date of September 16, 2025. The contract was placed with AmerisourceBergen's Corporate Office division located in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/mL syringes, valued at $9,104.04 under firm fixed price terms. The award, issued on August 7, 2025, with completion targeted for August 8, 2025, represents a child delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $12,084.12 delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of June 3, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Department's Medical Supply Chain awarded a $60,493.91 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Prolia 60 mg/ml syringes. This non-competitive, firm fixed-price delivery order is scheduled for completion by September 12, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics...
- The Defense Logistics Agency awarded a $26,999.75 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Prolia 60 mg/ml syringes. This firm fixed price contract is non-competitive with no set-aside designation and is scheduled for completion by August 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $29,291.77 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Prolia 60 mg/ml syringes. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation, indicating open...
- The Defense Logistics Agency awarded a $26,034.19 delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes under a firm fixed-price contract. The delivery order, issued on July 14, 2025, with an ultimate completion date of July 15, 2025, represents a competitively awarded non-set-aside procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,285.80 to AmerisourceBergen Drug Corp for the supply of Prolia 60 mg/ml syringes. The award, issued on May 15, 2025, with an ultimate completion date of May 16, 2025, was made under firm fixed price terms with no set-aside designation, indicating competitive award. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a Delivery Order valued at $14,887.74 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Prolia 60 mg/ml syringes. This non-set-aside, firm fixed price contract is scheduled for completion by August 20, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $12,121.41 to AmerisourceBergen Drug Corp for the supply of Prolia 60 mg/ml syringes. The contract, which is a child order under a larger vehicle, was awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, using firm fixed-price terms. The award was not designated as a set-aside contract, indicating it was competitively awarded. Performance will be fulfilled from AmerisourceBergen's location in...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTE80Delivery Order
The Defense Logistics Agency awarded a $7,575.13 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Prolia 60 mg/ml syringes. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The delivery is scheduled for completion by October 23, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement across the Defense Health Agency and other military healthcare systems. The company's DLA prime contract vehicle enables comprehensive pharmaceutical support globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical supplies. This delivery order for Prolia, an osteoporosis treatment, exemplifies the routine execution of AmerisourceBergen's federal contract obligations to supply specialized pharmaceutical products supporting military and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 10/22/25 |